Skip to main content
Log in

Increased salivary interleukin-6 levels in patients with primary Sjögren's syndrome

  • ORIGINAL ARTICLE
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

This study's purpose was to evaluate salivary interleukin-6 (IL-6) levels in patients with primary Sjögren's syndrome (SS). Salivary and serum IL-6 concentrations were evaluated by ELISA in 36 patients with SS and compared with 19 patients complaining of dry mouth and with normal controls. Salivary IL-6 levels were significantly elevated (P<0.01) in the 36 patients with SS as compared to the 19 patients with dry mouth (200.5±43.6 and 12.6±6.8 pg/ml, respectively). No significant differences were noted in the serum IL-6 levels between these two groups (105.8±17.1 and 84.8±17.1 pg/ml, respectively). Both salivary and serum IL-6 levels in the normal controls were below the level of detection of the assay. Positive correlation (r = 0.8613, P<0.0001) was found between salivary IL-6 levels and the focus score of labial biopsies in SS patients. Elevated salivary IL-6 levels appear to be a consequence of local production and may reflect the component of salivary gland inflammation in SS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 10 December 1997 / Accepted: 13 July 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tishler, M., Yaron, I., Shirazi, I. et al. Increased salivary interleukin-6 levels in patients with primary Sjögren's syndrome. Rheumatology International 18, 125–127 (1999). https://doi.org/10.1007/s002960050070

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002960050070

Navigation